Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: IEEE Trans Biomed Eng. 2018 Mar;65(3):625–634. doi: 10.1109/TBME.2017.2711529

Fig. 6.

Fig. 6

Qualitative performance representation for detection of nuclei (a) with normal organization in GBM; (b–c) having imaging artifacts; (d) having either vesicular or potentially necrotic phenotypes; (e) with viable GBM and infiltrating lymphocytes, (f–g) in the context of collagen and mammary gland architecture; and (h) with proliferating and pleomorphic tumor cells.